dna疫苗
免疫原性
免疫系统
结核分枝杆菌
抗原
病毒学
免疫学
生物
脾脏
肺结核
微生物学
医学
免疫
病理
作者
Yan Liang,Yajing Zhao,Xuejuan Bai,Li Xiao,Yourong Yang,Junxian Zhang,Lan Wang,Lei Guang Cui,Tong Wang,Ying-Chang Shi,Weiguo Zhao,Xueqiong Wu
出处
期刊:Autoimmunity
[Informa]
日期:2018-11-17
卷期号:51 (8): 417-422
被引量:12
标识
DOI:10.1080/08916934.2018.1546291
摘要
Tuberculosis (TB) is a major global public health problem. Latent TB infection (LTBI) is a major source of active TB. New vaccines to treat LTBI are urgently demanded. In this study, the gene encoding latency-associated antigen Rv3407 of Mycobacterium tuberculosis (MTB) rv3407 DNA vaccine was used to prepare and the immunogenicity and therapeutic effects were evaluated. Normal mice were immunized intramuscularly three times at two-week intervals with sterile water for injection, plasmid vector pVAX1, M. vaccae vaccine, ag85a DNA or rv3407 DNA. TB-infected mice were immunized intramuscularly three times at two-week intervals with phosphate-buffered saline (PBS) and rv3407 DNA. The normal mice immunized with rv3407 DNA or ag85a DNA showed higher levels of interferon-gamma (IFN-γ) in stimulated spleen lymphocyte culture supernatants, and had more Th1 cells and an elevated ratio of Th1/Th2 immune cells in whole blood, indicating that a Th1-type immune response was predominant. The levels of anti-Ag85A or anti-Rv3407 IgG antibody were significantly increased in the ag85a DNA and rv3407 DNA groups compared to the sterile water for injection, vector, and M. vaccae groups (p < .0001). Compared with the PBS group, the rv3407 DNA group had pulmonary bacterial loads that were lower by 0.56 log10 (p < .01). The mice vaccinated with rv3407 DNA developed antigen-specific cellular and humoral responses. The rv3407 DNA is a potential DNA vaccine candidate against TB.
科研通智能强力驱动
Strongly Powered by AbleSci AI